Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging

Published:1998-08 Issue:2 Volume:136 Page:307-313
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Shaffer Judy,Simbartl Loretta,Render Marta L.,Snow Elizabeth,Chaney Curtis,Nishiyama Hiroshi,Rauf George C.,Wexler Laura F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. The safety of intravenous dipyridamole thallium myocardial perfusion imaging;Ranhosky;Circulation,1990

2. Safety of intravenous dipyridamole for stress testing with thallium imaging;Homma;Am J Cardiol,1987

3. Dipyridamole thallium testing noncardiac side effects, cardiac effects, electrocardiographic changes, and hemodynamic changes after DPT infusion with and without exercise;Laarman;Int J Cardiol,1988

4. Dipyridamole thallium imaging: how safe is it?;Beller;Circulation,1990

5. Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthines;Holgate;J Allergy Clin Immunol,1984

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologic and Pharmacologic Stressors;Atlas of Nuclear Cardiology;2021

2. A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm;Toxicology and Applied Pharmacology;2017-02

3. Editorial: Regadenoson: An adenosine A2A receptor agonist for pharmacological myocardial perfusion imaging;Journal of Cardiology Cases;2014-08

4. Physiologic and Pharmacologic Stressors;Atlas of Nuclear Cardiology;2012-11-15

5. Hemodynamic response, arrhythmic risk, and overall safety of Regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients;The International Journal of Cardiovascular Imaging;2011-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3